E2F1 and ovarian carcinoma: PRMT5 has been found to methylate and destabilise E2F1 (47) and short interfering RNA (siRNA) knockdown of PRMT5 caused an increase in E2F1 mRNA and protein levels in ovarian cancer cells, resulting in decreased growth rate and induction of apoptosis (40).